Cargando…
Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
BACKGROUND: According to the result of the Cochrane review published in 2012, postoperative adjuvant chemotherapy (CTx) is associated with a survival benefit for rectal cancer patients operated for cure in comparison to patients who underwent only the surgical resection. AIM: To analyze the quality...
Autores principales: | Manzini, Giulia, Hapke, Fabius, Hines, Ian N, Henne-Bruns, Doris, Kremer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191332/ https://www.ncbi.nlm.nih.gov/pubmed/32368327 http://dx.doi.org/10.4251/wjgo.v12.i4.503 |
Ejemplares similares
-
Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials
por: Manzini, Giulia, et al.
Publicado: (2020) -
Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials
por: Manzini, Giulia, et al.
Publicado: (2017) -
Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study
por: Bauer, Katrin, et al.
Publicado: (2023) -
Severe complications after mesh migration following abdominal hernial repair: report of two cases and review of literature
por: Manzini, Giulia, et al.
Publicado: (2019) -
Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines
por: Manzini, Giulia, et al.
Publicado: (2017)